A multi-award-winning pharmaceutical executive, Terrell “Terry” Herring serves as president of commercial operations for Mission Pharmacal Company, a privately held pharmaceutical firm. Terrell “Terry” Herring plays a leading role in the company’s various subsidiaries including serving as president of Alamo Pharma Services. Alamo Pharma provides integral solutions to biotech and pharmaceutical firms which successfully usher their products to market in a cost-effective manner. The company recently announced a strategic partnership with Thingee Corporation, a life sciences-focused software company, wherein Alamo will utilize Thingee’s new iDetail™ enterprise content delivery platform. Specifically designed for iPad, iDetail enables Alamo’s sales representatives to rapidly access their latest audio/video files and presentations, as well as other sales and detailing aids. The software platform features touch interface and outstanding visual display while also having the capability to collect detailing call data in real time backed by powerful analytics. This platform will help representatives to engage physicians and their office staff members in a more lively and effective way, leading to increased sales team productivity.
0 Comments
A magna cum laude graduate of the Citadel Military College of South Carolina, Terrell Herring holds a bachelor of science degree in biology. Terrell Herring serves both as president of commercial operations with Mission Pharmacal Company and as president of Alamo Pharma Services. Outside of work, Herring is an active community volunteer and has served on the board of the Kirkwood-Brainerd Camp. Located in Stroudsburg, Pennsylvania, Kirkwood-Brainerd Camp is a joint mission of the Presbytery of Philadelphia and Lehigh Presbytery, and provides a valuable opportunity for young people to enrich their spiritual lives in a safe and supportive environment. The camp is located in the Poconos Mountains of Eastern Pennsylvania and offers week-long traditional summer program activities such as swimming, boating, and hiking as well as themed options that range from crafts and music to solving mysteries. According to the camp’s mission, campers have the opportunity to live the gospel while engaging in fun activities and fellowship. A tiered pricing system aims to make faith-based summer camp accessible to everyone, regardless of financial means. As Mission Pharmacal’s president of commercial operations, Terrell Herring oversees strategy and brand positioning for the company. In addition, he focuses on product development and key new hires. Under Terrell Herring’s leadership, Mission Pharmacal also has succeeded in forging profitable new partnerships. At the beginning of 2018, Mission Pharmacal announced that it had established a partnership with Fabre-Kramer Pharmaceuticals, Inc., on a project to manufacture the antidepressant medication Travivo in extended-release tablet form. Travivo (generic name Gepirone HCL) is designed to treat generalized anxiety disorder. The two companies have elected to facilitate the transfer of the Fabre-Kramer technology to Mission for the making of registration batches of Travivo. Travivo’s advantages include its ability to function in the body without causing the types of chemical dependency, amnesia, and sexual dysfunctions that are often among the common side-effects of competing products. After Mission produces the registration batches, executives will submit the associated data to the US Food and Drug Administration as part of the agency’s review and approval process. Following anticipated FDA approval, Mission and Fabre-Kramer will focus on their joint agreement for Mission’s ongoing production of Travivo. Terrell Herring serves as president of Alamo Pharma Services, a subsidiary company of Mission Pharmacal. At the latter firm, he additionally assists in directing strategic decision-making as commercial operations president. Terrell Herring and Alamo Pharma recently announced the company’s participation in a major Washington, DC conference designed to better acquaint attendees with how government regulatory processes affect innovations in the pharmaceutical industry. Alamo Pharma served as a sponsor of the FDA/CMS Summit, held toward the close of 2017. In addition, the company’s chief operating officer Peter Marchesini spoke as a member of a panel discussing the future of product-related communications, with specific reference to off-label developments. Mr. Marchesini’s panel group was moderated by journalist M. Nielsen Hobbs, whose decades of experience have informed his coverage of the pharmaceutical industry. The panel discussed the ongoing needs for training of company representatives in product knowledge and compliance requirements, and for overall fairness in labeling. KNect365, part of the Informa family of companies, hosted the summit, which also provided corporate leaders the opportunity to connect directly with regulators on issues involving formulary protocols. A biology graduate from The Citadel, Military College of South Carolina, Terrell “Terry” Herring has served as president of commercial operations at Mission Pharmacal since 2010. A resident of Pennsylvania, Terrell Herring was recognized by PharmaVOICE among its 2017 Red Jacket honorees. PharmaVOICE Red Jacket honorees are individuals that are selected by their colleagues, peers, and even competitors among the PharmaVOICE 100 multiple times. They are passionate men and women drawn from the entire life sciences industry including pharmaceuticals, biopharmaceutical, biotechnology, clinical research, patient education, advertising, and academia, who have raised the bar with regard to exemplary industry practice and leadership. They challenge others, disrupt the status quo, and focus on the long-term vision of better health outcomes, not short-term profits. Launched in 2014, the coveted Red Jacket list, widely referred to as the industry’s Hall of Fame, includes honorees like: -Nicholas Colucci, president of Publicis Healthcare Communications Group, a leading healthcare communications platform -Jeffrey Berkowitz, president of Walgreens Boots Alliance Development GmbH which provides solutions to the global challenges pharmaceuticals face -Amir Kalali, MD, vice president and global head of Neuroscience Center of Excellence. Amir is widely respected in the life sciences industry for his expertise in fast-tracking product development through innovation and strategic collaboration. Terrell Herring serves as a member of the leadership team of Mission Pharmacal as its president of commercial operations. He also directs the operations of that company’s subsidiary Alamo Pharma Services as president. Beyond his professional endeavors, Terrell Herring serves on the Board of Directors of Bridging the Gap Africa, which sends volunteers into rural Kenyan communities to help construct footbridges over otherwise dangerous or impassable rivers. Many people in the East African country have no choice but to walk to get from one place to another, yet Kenya’s terrain is such that without good bridges, large numbers of adults could not hold jobs or take their crops to market; many children could not go to school; and numerous families would lack access to adequate health care. In one recent 10-year period, rain-inundated Kenyan ravines led to the deaths of some 6,000 people. Designing and building these bridges takes time, skill, and often back-breaking work. Construction projects can involve the shifting of many tons of sand, gravel, and other materials. But people around the world continue to reach out to help in numerous ways. For example, in 2013, a group of engineering students at the University of Buffalo framed their senior class project around designing new steel-supported, hanging footbridges and shared the designs with Bridging the Gap Africa. As commercial operations president for Texas-based Mission Pharmacal and president of the Mission subsidiary Alamo Pharma Services, Terrell Herring provides market-focused, strategic leadership to the companies’ teams. Honored with a 2017 Red Jacket by the industry resource PharmaVOICE, Terrell Herring is also a philanthropist, whose long-lasting commitment to the nonprofit group A New Equilibrium includes current service on its board of directors. A New Equilibrium, or ANE, brings business executives together to support one another in creating balance, personal and professional integrity, and a greater spiritual focus in their lives. The organization’s core values include the insight that an individual’s intentional spiritual development provides him or her with the ability to become a better, more effective, and more inspiring leader. On its website, ANE promotes a range of associated resources, including the 2012 book The Joy of Work: How to Stay Calm, Confident and Collected in a Chaotic World. Written by executive coach Stephen G. Payne, the book has garnered praise as an informative tool for executives who want to increase their abilities to get more out of work and life, and to make a lasting difference. Its emphasis on powering one’s own inner drive for integrity and achievement has proven a life-changing message for a wide range of readers. The president of Alamo Pharma Services, Terrell “Terry” Herring provides strategic leadership for all aspects of the company’s operations. Also the president of commercial operations at Mission Pharmacal Company, Terrell Herring works with a dedicated team to fulfill unmet healthcare needs in the country. One of these needs is prenatal vitamins. Less than half of pregnant women in the United States take prenatal vitamins before pregnancy, according to research conducted by The Harris Poll and sponsored by March of Dimes. The research, summarized in a report titled Prenatal Health & Nutrition Survey, queried over 1,000 women between the ages of 18 and 45. The survey was conducted online. Researchers found that only 34 percent of women took multivitamins before finding out they were pregnant. The number was lower for Hispanic women (27 percent) and African-American women (10 percent). This is very alarming, since almost 50 percent of pregnancies in the country are unplanned and many birth defects, such as neural tube defects (NTDs), occur in the first month of pregnancy. This means that women who do not take enough NTD-preventing multivitimins with folic acid before pregnancy and in its early stages have a higher likelihood of giving birth to babies with NTDs. Researchers found two reasons for the late uptake of prenatal vitamins. The first was a lack of public education on the importance of multivitamins before pregnancy. The second was the cost of prenatal care, especially among Hispanic women. Mission Pharmacal Company is working to ensure as many women get access to critical multivitamins before and during pregnancy as possible. In addition to serving as president of commercial operations at Mission Pharmacal, Terrell “Terry” Herring is active with the subsidiaries Alamo Pharma Services, BexR Logistix, BioComp Pharmaceuticals, Epic Fulfillment, Integrus Pharmaceuticals, and ProSolus Pharma. Alongside his activities with the Mission Family of Companies, Terrell Herring serves on the Advisory Board of BioAgilytix, one of the world’s leading bioanalytical testing laboratories. Thanks to a recent expansion of the laboratory at its US headquarters, BioAgilytix now has the capability to accommodate even the largest Phase III bioanalytical studies. The expansion added nearly 21,000 square feet to the North Carolina-based facility, which now features over 48,000 square feet of state-of-the-art lab space. BioAgilytix, which specializes in large molecule analysis, designed the expansion to improve its capacity and technology for studies involving components such as cell-based assays, biomarkers, and immunogenicity. During the build-out, the company also focused on maintaining its status as one of the industry’s leading Good Manufacturing Practice facilities, a distinction that displays its commitment to upholding quality standards and industry best practices. An executive at Mission Pharmacal and its subsidiary Alamo Pharma Services, Terrell (Terry) Herring spoke on leveraging partnerships to achieve success and growth at the 2015 Global Alliance Summit of the Association of Strategic Alliance Professionals. Alongside his career in the pharmaceutical industry, Terrell Herring supports a variety of charitable causes including the March of Dimes. Founded to help babies born prematurely, the March of Dimes raises funds to provide crucial care and treatment for infants in the neonatal intensive care unit. March of Dimes relies on dedicated volunteers to raise the money to help these infants and their families. In order to assist volunteers in fundraising and spreading the word about this important cause, the March of Dimes offers a diverse range of materials on its website, including printable posters and business cards. Through the site, you can also send free e-cards, find social media memes and blog widgets, and download the March of Dimes app to help you share your progress and contact possible donors. |
AuthorTerrell Herring began working at Mission Pharmacal Company in 2010, bringing more than 25 years of experience in the pharmaceutical industry to his role as President of Commercial Operations. Archives
February 2018
Categories
All
|